Ascendis Pharma A/S Overview
Ascendis Pharma A/S Target Price
Analysts' 12-month price predictions for ASND.
Share Price
$124.04
Average Target Price
$191.00
54% upside
54% upside1 analysts in the last 4 months
High: $191 | Low: $191
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2024-03-14 | Evercore ISIJosh Schimmer | $191 | 54% upside |  |
| 2023-01-03 | Wells Fargo | $177 | 42.7% upside | |
| 2022-11-15 | Morgan Stanley | $148 | 19.3% upside | |
| 2022-11-14 | Leerink Partners | $148 | 19.3% upside | |
| 2022-11-14 | Wedbush | $164 | 32.2% upside | |
| 2022-03-20 | Bank of America SecuritiesTazeen Ahmad | $161 | 29.8% upside | |
| 2022-02-28 | CitigroupDavid Lebovitz | $187 | 50.8% upside | |
| 2022-01-06 | Cowen & Co.Yaron Werber | $136 | 9.6% upside | |
| 2021-07-07 | Canaccord GenuityMichelle Gilson | $196 | 58% upside | |
| 2021-06-14 | Cantor FitzgeraldAlethia Young | $201 | 62% upside | |